Brazil is in the midst of political turmoil as impeachment proceedings move forward against the country's president Dilma Rousseff. What's next for the country and its government?
Guest Host: Steve Roberts
Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.
- Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Marc Kaufman reporter on the national desk of "The Washington Post"
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
Most Recent Shows
Since 2005 nearly 800 reporters have been killed while doing their work. Please join us to talk about the risks reporters face around the world and new effort to boost press safety and freedoms.
Some say eating insects could save the planet, as we face the potential for global food and protein shortages. It's a common practice in many parts of the world, but what would it take to make bugs more appetizing to the masses here in the U.S.? Does it even make sense to try? A look at the arguments for and against the practice known as entomophagy, and the cultural and environmental issues involved.
All three GOP candidates gather in California for a statewide convention. Prospects for front-runner Donald Trump as the nomination race heads into the final stretch, the ongoing divide within the party and what it all means for the general election.